ANNAMARIE PAULSEN: Open Payments
NPI 1285766055 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 96 payments from 17 companies in 2025. Trend: 2023 $1,941 · 2024 $2,331 · 2025 $1,970
Food & beverage: $1,859Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $344 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $275 |
| Otsuka America Pharmaceutical, Inc. | 13 | $250 |
| Vanda Pharmaceuticals Inc. | 7 | $189 |
| Axsome Therapeutics, Inc. | 7 | $165 |
| Teva Pharmaceuticals USA, Inc. | 2 | $135 |
| Tris Pharma Inc | 5 | $108 |
| Corium, LLC | 9 | $88 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Lundbeck LLC | 3 | $69 |
Products named: INGREZZA, CAPLYTA, REXULTI, Auvelity, FANAPT, Azstarys, Jornay PM, Onyda XR.
Industry payments across GA — which companies pay providers there.
